Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94424849 | 9442484 | 9 | F | 20150309 | 20130806 | 20160705 | EXP | US-JNJFOC-20130801000 | JANSSEN | JUILLERAT P, SOKOL HV, YAJNIK, FROEHLICH F, BEAUGERIE L, COSNES J, ET AL. FACTORS ASSOCIATED WITH DURABLE RESPONSE TO INFLIXIMAB 5 YEARS AND BEYOND: A MULTI CENTER INTERNATIONAL COHORT. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL 21ST UNITED EUROPEAN GASTROENTEROLOGY WEEK BERLIN GERMANY OCT-2013;1 (1 SUPPL. 1):A33. JUILLERAT P, SOKOL H, YAJNIK V, FROEHLICH F, BEAUGERIE L, COSNES J, ET AL. FACTORS ASSOCIATED WITH DURABLE RESPONSE TO INFLIXIMAB 5 YEARS AND BEYOND: A MULTI CENTER INTERNATIONAL. AGA AB | 0.00 | Y | 0.00000 | 20160705 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94424849 | 9442484 | 1 | PS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | U | UNKNOWN | 103772 | LYOPHILIZED POWDER |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 94424849 | 9442484 | 1 | Crohn's disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 94424849 | 9442484 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 94424849 | 9442484 | Adverse drug reaction | |
| 94424849 | 9442484 | Bacterial infection | |
| 94424849 | 9442484 | Drug ineffective | |
| 94424849 | 9442484 | Infusion related reaction | |
| 94424849 | 9442484 | Lupus-like syndrome | |
| 94424849 | 9442484 | Neurological symptom | |
| 94424849 | 9442484 | Psoriasis | |
| 94424849 | 9442484 | Rheumatic disorder | |
| 94424849 | 9442484 | Skin disorder | |
| 94424849 | 9442484 | Systemic lupus erythematosus | |
| 94424849 | 9442484 | Therapeutic response decreased | |
| 94424849 | 9442484 | Viral infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |